276 related articles for article (PubMed ID: 26814720)
21. [Comorbidities of COPD].
Brinchault G; Diot P; Dixmier A; Goupil F; Guillais P; Gut-Gobert C; Leroyer C; Marchand-Adam S; Meurice JC; Morel H; Person C; Cavaillès A
Rev Pneumol Clin; 2015 Dec; 71(6):342-9. PubMed ID: 26585876
[TBL] [Abstract][Full Text] [Related]
22. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
[TBL] [Abstract][Full Text] [Related]
23. Proportion of gastroesophageal reflux symptoms in patients with chronic obstructive pulmonary disease.
Phulpoto MA; Qayyum S; Rizvi N; Khuhawar SM
J Pak Med Assoc; 2005 Jul; 55(7):276-9. PubMed ID: 16108509
[TBL] [Abstract][Full Text] [Related]
24. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease.
Corlateanu A; Covantev S; Mathioudakis AG; Botnaru V; Siafakas N
Respir Investig; 2016 Nov; 54(6):387-396. PubMed ID: 27886849
[TBL] [Abstract][Full Text] [Related]
26. Comorbidities and their impact on chronic obstructive pulmonary disease.
Dursunoğlu N; Köktürk N; Baha A; Bilge AK; Börekçi Ş; Çiftçi F; Gezmen Karadağ M; Çalık Kütükçü E; Noyan A; Polatlı M; Önen ZP; Sarınç S; Umut S; Uzaslan E; Kubat Üzüm A; Akkoca Yıldız Ö;
Tuberk Toraks; 2016 Dec; 64(4):289-298. PubMed ID: 28393718
[TBL] [Abstract][Full Text] [Related]
27. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
[TBL] [Abstract][Full Text] [Related]
28. Strategies for reducing the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease.
Ferri C
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):103-11. PubMed ID: 25655487
[TBL] [Abstract][Full Text] [Related]
29. The revised GOLD 2017 COPD categorization in relation to comorbidities.
Kahnert K; Alter P; Young D; Lucke T; Heinrich J; Huber RM; Behr J; Wacker M; Biertz F; Watz H; Bals R; Welte T; Wirtz H; Herth F; Vestbo J; Wouters EF; Vogelmeier CF; Jörres RA
Respir Med; 2018 Jan; 134():79-85. PubMed ID: 29413512
[TBL] [Abstract][Full Text] [Related]
30. [Chronic obstructive pulmonary disease (COPD)].
Ogawa H; Hida W
Nihon Rinsho; 2009 Aug; 67(8):1518-24. PubMed ID: 19768934
[TBL] [Abstract][Full Text] [Related]
31. Comorbidome, Pattern, and Impact of Asthma-COPD Overlap Syndrome in Real Life.
van Boven JF; Román-Rodríguez M; Palmer JF; Toledo-Pons N; Cosío BG; Soriano JB
Chest; 2016 Apr; 149(4):1011-20. PubMed ID: 26836892
[TBL] [Abstract][Full Text] [Related]
32. [Comorbidities in COPD: a new challenge in clinical practice].
Couillard A; Veale D; Muir JF
Rev Pneumol Clin; 2011 Jun; 67(3):143-53. PubMed ID: 21665077
[TBL] [Abstract][Full Text] [Related]
33. Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.
Putcha N; Drummond MB; Wise RA; Hansel NN
Semin Respir Crit Care Med; 2015 Aug; 36(4):575-91. PubMed ID: 26238643
[TBL] [Abstract][Full Text] [Related]
34. Gastroesophageal reflux symptoms and nasal symptoms affect the severity of bronchitis symptoms in patients with chronic obstructive pulmonary disease.
Hasegawa K; Sato S; Tanimura K; Fuseya Y; Uemasu K; Hamakawa Y; Sato A; Mishima M; Muro S; Hirai T
Respir Investig; 2018 May; 56(3):230-237. PubMed ID: 29773294
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic review.
Wrobel JP; Thompson BR; Williams TJ
J Heart Lung Transplant; 2012 Jun; 31(6):557-64. PubMed ID: 22502811
[TBL] [Abstract][Full Text] [Related]
36. The cardiovascular phenotype of Chronic Obstructive Pulmonary Disease (COPD): Applying machine learning to the prediction of cardiovascular comorbidities.
Nikolaou V; Massaro S; Garn W; Fakhimi M; Stergioulas L; Price D
Respir Med; 2021 Sep; 186():106528. PubMed ID: 34260974
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD).
Izquierdo-Alonso JL; Rodriguez-Gonzálezmoro JM; de Lucas-Ramos P; Unzueta I; Ribera X; Antón E; Martín A
Respir Med; 2013 May; 107(5):724-31. PubMed ID: 23419828
[TBL] [Abstract][Full Text] [Related]
38. Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?
Iliaz S; Iliaz R; Onur ST; Arici S; Akyuz U; Karaca C; Demir K; Besisik F; Kaymakoglu S; Akyuz F
Respir Med; 2016 Jun; 115():20-5. PubMed ID: 27215499
[TBL] [Abstract][Full Text] [Related]
39. Multidimensional approach for the proper management of a complex chronic patient with chronic obstructive pulmonary disease.
Rogliani P; Brusasco V; Fabbri L; Ungar A; Muscianisi E; Barisone I; Corsini A; De Angelis G
Expert Rev Respir Med; 2018 Feb; 12(2):103-112. PubMed ID: 29241393
[TBL] [Abstract][Full Text] [Related]
40. Preclinical murine models of Chronic Obstructive Pulmonary Disease.
Vlahos R; Bozinovski S
Eur J Pharmacol; 2015 Jul; 759():265-71. PubMed ID: 25818750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
